Drug Discovery and Development Analysis & Statistics, January 2013 (p50)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1471-1510 of about 3 200 reports

Purchase Reports From Reputable Market Research Publishers

Interleukin-5 (IL-5) Inhibitors -Pipeline Insights, 2014

Interleukin-5 (IL-5) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-5 (IL-5) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2014

Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-16 (IL-16) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2014

Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-17 (IL-17) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-8 (IL-8) Inhibitors -Pipeline Insights, 2014

Interleukin-8 (IL-8) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-8 (IL-8) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-23 (IL-23) Inhibitors -Pipeline Insights, 2014

Interleukin-23 (IL-23) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-23 (IL-23) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Interleukin-4 (IL-4) Inhibitors -Pipeline Insights, 2014

Interleukin-4 (IL-4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Interleukin-4 (IL-4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Ionotropic Glutamate Receptor Antagonists -Pipeline Insights, 2014

Ionotropic Glutamate Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ionotropic Glutamate Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Janus Kinase (JAK) Inhibitors -Pipeline Insights, 2014

Janus Kinase (JAK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase (JAK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights, 2014

Janus Kinase (JNK) Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Janus Kinase (JNK) Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Kainate Receptor Antagonists -Pipeline Insights, 2014

Kainate Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Kainate Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Kallikrein Inhibitors -Pipeline Insights, 2014

Kallikrein Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Kallikrein Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Kappa Antagonists -Pipeline Insights, 2014

Kappa Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Kappa Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Killer Cell Immunoglobulin-Like Receptor (KIR) Inhibitors -Pipeline Insights, 2014

Killer Cell Immunoglobulin-Like Receptor (KIR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Killer Cell Immunoglobulin-Like Receptor (KIR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Leptin Receptor (LEP-R) Agonists -Pipeline Insights, 2014

Leptin Receptor (LEP-R) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Leptin Receptor (LEP-R) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors -Pipeline Insights, 2014

Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Leukotriene Antagonists -Pipeline Insights, 2014

Leukotriene Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Leukotriene Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Leukotriene D4 Antagonists -Pipeline Insights, 2014

Leukotriene D4 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Leukotriene D4 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Lipoprotein Lipase Activators -Pipeline Insights, 2014

Lipoprotein Lipase Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lipoprotein Lipase Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Lipoxygenase Inhibitors (LOX Inhibitor) -Pipeline Insights, 2014

Lipoxygenase Inhibitors (LOX Inhibitor) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lipoxygenase Inhibitors (LOX Inhibitor)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
LTB4 Antagonists -Pipeline Insights, 2014

LTB4 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“LTB4 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Lysine Specific Demethylase 1 (LSD-1) Inhibitors -Pipeline Insights, 2014

Lysine Specific Demethylase 1 (LSD-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lysine Specific Demethylase 1 (LSD-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
M2 Proton Channel Inhibitors -Pipeline Insights, 2014

M2 Proton Channel Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“M2 Proton Channel Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Matrix Metalloproteinase (MMP) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase (MMP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase (MMP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Maturation Inhibitors -Pipeline Insights, 2014

Maturation Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Maturation Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Melanocortin 4 Receptor (MC4R) Agonists -Pipeline Insights, 2014

Melanocortin 4 Receptor (MC4R) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Melanocortin 4 Receptor (MC4R) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Metabotropic Glutamate Receptor Agonists -Pipeline Insights, 2014

Metabotropic Glutamate Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Metabotropic Glutamate Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights, 2014

Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Methionine Aminopeptidase 2 (Metap2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
mGlu2 Agonists -Pipeline Insights, 2014

mGlu2 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“mGlu2 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
mGlu2 Antagonists -Pipeline Insights, 2014

mGlu2 Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“mGlu2 Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
mGlu3 Agonists -Pipeline Insights, 2014

mGlu3 Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“mGlu3 Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development

82 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.